Aspiriant, LLC Becton Dickinson & CO Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Aspiriant, LLC holds 1,171 shares of BDX stock, worth $262,304. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,171

Previous 1,080 8.43%

Holding current value

$262,304

Previous $252,000 11.9%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$221.47 - $242.41 $20,153 - $22,059	91 Added 8.43%	1,171 $282,000
Q2 2024 Jul 15, 2024	SELL	$225.07 - $246.17 $17,555 - $19,201	-78 Reduced 6.74%	1,080 $252,000
Q1 2024 Apr 15, 2024	SELL	$233.45 - $247.73 $6,069 - $6,440	-26 Reduced 2.2%	1,158 $286,000
Q4 2023 Jan 26, 2024	SELL	$232.24 - $267.23 $3,483 - $4,008	-15 Reduced 1.25%	1,184 $288,000
Q3 2023 Oct 17, 2023	BUY	$254.9 - $283.59 $2,803 - $3,119	11 Added 0.93%	1,199 $309,000
Q4 2022 Jan 23, 2023	BUY	$218.29 - $256.91 $22,920 - $26,975	105 Added 9.7%	1,188 $0
Q3 2022 Oct 28, 2022	SELL	$51.03 - $264.23 $663 - $3,434	-13 Reduced 1.19%	1,083 $241,000
Q2 2022 Jul 25, 2022	SELL	$234.74 - $275.42 $8,450 - $9,915	-36 Reduced 3.18%	1,096 $271,000
Q1 2022 May 06, 2022	SELL	$243.64 - $270.48 $487 - $540	-2 Reduced 0.18%	1,132 $302,000
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $34,051 - $37,139	148 Added 15.01%	1,134 $286,000
Q3 2021 Oct 27, 2021	BUY	$232.72 - $256.47 $232 - $256	1 Added 0.1%	986 $242,000
Q2 2021 Aug 13, 2021	BUY	$232.65 - $254.58 $2,326 - $2,545	10 Added 1.03%	985 $238,000
Q1 2021 May 11, 2021	SELL	$232.09 - $256.88 $1,856 - $2,055	-8 Reduced 0.81%	975 $236,000
Q4 2020 Feb 01, 2021	SELL	$221.92 - $245.94 $443 - $491	-2 Reduced 0.2%	983 $247,000
Q3 2020 Oct 29, 2020	BUY	$215.77 - $276.76 $215 - $276	1 Added 0.1%	985 $230,000
Q2 2020 Aug 06, 2020	SELL	$219.9 - $263.41 $29,026 - $34,770	-132 Reduced 11.83%	984 $235,000
Q1 2020 May 05, 2020	SELL	$195.69 - $279.01 $24,265 - $34,597	-124 Reduced 10.0%	1,116 $256,000
Q3 2019 Nov 04, 2019	SELL	$230.58 - $256.08 $7,378 - $8,194	-32 Reduced 2.52%	1,240 $314,000
Q2 2019 Aug 06, 2019	SELL	$217.4 - $246.08 $31,088 - $35,189	-143 Reduced 10.11%	1,272 $320,000
Q1 2019 May 03, 2019	SELL	$206.05 - $248.17 $25,550 - $30,773	-124 Reduced 8.06%	1,415 $352,000
Q4 2018 Feb 04, 2019	SELL	$204.73 - $257.93 $24,567 - $30,951	-120 Reduced 7.23%	1,539 $345,000
Q3 2018 Oct 26, 2018	BUY	$233.07 - $256.0 $35,426 - $38,912	152 Added 10.09%	1,659 $432,000
Q2 2018 Aug 07, 2018	BUY	$208.1 - $233.85 $9,988 - $11,224	48 Added 3.29%	1,507 $361,000
Q1 2018 May 04, 2018	BUY	$205.46 - $240.27 $299,766 - $350,553	1,459 New	1,459 $316,000
Q4 2017 Jan 31, 2018	SELL	$189.0 - $222.64 $282,933 - $333,292	-1,497 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $279,774 - $297,753	1,497	1,497 $293,000

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account